Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment.

Kloth, Jacqueline S L

Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment. [electronic resource] - European journal of cancer (Oxford, England : 1990) Mar 2016 - 101-106 p. digital

Publication Type: Journal Article

1879-0852

10.1016/j.ejca.2015.12.019 doi


Antineoplastic Agents--adverse effects
Carcinoma, Renal Cell--blood
Disease-Free Survival
Erythrocyte Indices
Erythrocytes--drug effects
Female
Hemoglobins--metabolism
Humans
Indoles--adverse effects
Kidney Neoplasms--blood
Male
Molecular Targeted Therapy
Predictive Value of Tests
Proportional Hazards Models
Protein Kinase Inhibitors--adverse effects
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrroles--adverse effects
Retrospective Studies
Risk Factors
Sunitinib
Time Factors
Treatment Outcome